search
Back to results

Implementation of Family Involvement for Persons With Psychotic Disorders. (IFIP)

Primary Purpose

Psychotic Disorders

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Implementation support program
Sponsored by
University of Oslo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Psychotic Disorders focused on measuring Family psychoeducation, Schizophrenia, Implementation science, Mental health care services, Clinical ethics, Family involvement, Family intervention

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Eligibility criteria apply to participants in both quantitative and qualitative sub-studies, except that participation in family psychoeducation as described below is NOT an exclusion criterion in the qualitative sub-study.

Inclusion criteria for patients:

  • To have an established psychotic disorder (F20-29 in ICD-10) or a tentative diagnosis of psychotic disorder, certain enough to begin treatment. This need not be the patient's primary diagnosis.
  • To be 18 years or older at the time of inclusion.

Exclusion criteria for patients:

  • To be sentenced to psychiatric treatment.
  • Not being competent to consent to participation in research.
  • Having completed more than five joint sessions of family psychoeducation in single-family groups (patient and relative together) or more than ten joint sessions (multiple families together) in multiple-family groups, or a similarly structured family intervention.
  • Not having any relatives or next of kin.

Inclusion criteria for relatives:

  • Being a relative of a patient with a diagnosis as described above.
  • To be 18 years or older at the time of inclusion.

Exclusion criteria for relatives:

• Having completed more than five joint sessions (patient and relative together) of family psychoeducation in single-family groups or more than ten joint sessions (multiple families together) in multiple-family groups, or a similarly structured family intervention.

Sites / Locations

  • Asker DPS - Vestre Viken HF
  • Drammen DPS - Vestre Viken HF
  • Ringerike DPS - Vestre Viken HF
  • Kongsberg DPS - Vestre Viken HF
  • DPS poliklinikk Vestmar/stathelle - Sykehuset Telemark
  • Vestfold DPS - Sykehuset i Vestfold HF
  • Nedre Romerike DPS - Akershus Universitetssykehus HF
  • Groruddalen DPS - Akershus Universitetssykehus HF
  • Søndre Oslo DPS - Oslo Universitetssykehus HF
  • Voksenpsykiatrisk avdeling Vinderen - Diakonhjemmet Sykehus
  • DPS poliklinikk Porsgrunn - Sykehuset Telemark
  • Bærum DPS -Vestre Viken HF
  • DPS poliklinikk Seljord - Sykehuset Telemark
  • DPS poliklinikk Skien - Sykehuset Telemark
  • Vestfold DPS - Sykehuset i Vestfold HF

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

No Intervention

Arm Label

Intervention arm

Control arm

Arm Description

Clusters (psychiatric outpatient clinics) in the intervention arm receives a comprehensive implementation support program during the trial period.

Clusters (psychiatric outpatient clinics) in the control arm receives no implementation support during the trial period.

Outcomes

Primary Outcome Measures

Implementation study: Fidelity to the intervention model - Family psychoeducation 1
Change in score on fidelity scale for performance and content of family psychoeducation. Rated from 1 (low) to 5 (high).
Implementation study: Fidelity to the intervention model - Family psychoeducation 2
Change in score on fidelity scale for penetration rate and general organisation of family psychoeducation. Rated from 1 (low) to 5 (high).
Implementation study: Fidelity to the intervention model - Family involvement and support 1
Change in total fidelity measured by the fidelity scale for family involvement and support. Rated from 1 (low) to 5 (high).
Implementation study: Fidelity to the intervention model - Family involvement and support 2
Change in penetration rate, measured by the fidelity scale for family involvement and support. Rated from 1 (low) to 5 (high).
Implementation study: Fidelity to the intervention model - Family involvement and support 3
Change in content, structure and implementation, measured by the scale for family involvement and support. Rated from 1 (low) to 5 (high).

Secondary Outcome Measures

Patient quantitative sub-study: Patient experiences of their own mental health and functioning.
The Behavior and Symptom Identification scale - (BASIS-24) with 24 questions on mental health, functioning and substance use, on a scale 1-5. Completed by patients.
Patient quantitative sub-study and economic sub-study: Quality of life
The Recovering Quality of Life - (ReQoL-10) questionnaire with 10 mental health items, and one physical health item on a scale 1-5. Completed by patients.
Patient quantitative sub-study: General satisfaction.
The Manchester Short Assesment of Quality of Life - (MANSA) questionnaire - first question only, on a scale 1-7. Completed by patients.
Patient quantitative sub-study: Experienced burden of mental health problems.
A single question - Produced for this study on a scale 1-7. Completed by patients.
Patient quantitative sub-study: Perceived warmth and criticism from relative.
Hooley 1989 - 5 items rated 1-10. Completed by patients.
Patient quantitative sub-study: Experienced shared decision making.
The CollaboRATE questionnaire (3 items rated 0-9), plus two additional items. Completed by patients.
Patient quantitative sub-study: Adherence with medication
A single question answered by patient, relative and clinician.
Patient quantitative sub-Study: Clinician assessment of patient mental health and functioning
Health of the Nation Outcome Scale - (HoNOS) scale rated by clinicians on 12 items rated 0-4 (no problem - very serious problem).
Patient quantitative sub-study: Clinician assessment of patient global functioning
Global Assessment of Functioning Scale - (GAF), split version for symptoms and functioning
Patient quantitative sub-study and economic sub-study: Change in number of hospital admissions.
Retrieved from the Norwegian patient registry.
Patient quantitative sub-study and economic sub-study: Change in number of days spent admitted to hospital.
Retrieved from the Norwegian patient registry.
Relative quantitative sub-study and economic sub-study: Caregiver quality of life 1
The Care Related Quality of Life - (CarerQoL) questionnaire - Seven questions on a three-point scale. Completed by relatives.
Relative quantitative sub-study and economic sub-study: Caregiver quality of life 2
The Care Related Quality of Life - (CarerQoL) questionnaire - One visual analogue scale (VAS)-question on an 11-point scale, which is also part of the same measure. Completed by relatives.
Relative quantitative sub-study: Experience of caregiving
The Experience of Caregiving inventory - (ECI) questionnaire - 66 items on a five-point scale covering various aspects of being a caregiver. Completed by relatives.
Relative quantitative sub-study: Expressed emotion
The Family questionnaire - (FQ) - 20 items on a four-point scale, measuring criticism and emotional over-involvement. Completed by relatives.
Relative quantitative sub-study: Experienced involvement and shared decision making
An adapted version of the CollaboRATE questionnaire (3 items rated 0-9), plus two additional items completed by relatives.
Relative quantitative sub-study: Experienced support
Carer Well-being and Support questionnaire (CWS) v2 short part B - 18 items rated on a four-point scale. Completed by relatives.
Patients' and relatives' quantitative sub-studies and economic sub-study: Use of public health services and resources.
Patients' and relatives' use of public health services and resources: Number of appointments with health services, investigations, treatments and medical prescriptions, translated into costs. Retrieved from national registries.
Patients' and relatives' quantitative sub-studies and economic sub-study: Work participation
Patients' and relatives' work participation measured in percentage of a regular full time position. Retrieved from national registries.
Economic sub-study: Increased costs related to implementing and practicing family involvement
Increased costs related to implementing and practicing family involvement in the clinical units in the intervention arm. Compared to normal costs before baseline.

Full Information

First Posted
February 28, 2019
Last Updated
January 3, 2023
Sponsor
University of Oslo
Collaborators
Oslo Metropolitan University, University Hospital, Akershus, Helse Fonna, Diakonhjemmet Hospital, Vestre Viken Hospital Trust, Oslo University Hospital, Sykehuset i Vestfold HF, Sykehuset Telemark, The Research Council of Norway, Helse Sor-Ost
search

1. Study Identification

Unique Protocol Identification Number
NCT03869177
Brief Title
Implementation of Family Involvement for Persons With Psychotic Disorders.
Acronym
IFIP
Official Title
Implementation of Guidelines on Family Involvement for Persons With Psychotic Disorders in Community Mental Health Centres. A Cluster Randomised Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Completed
Study Start Date
March 21, 2019 (Actual)
Primary Completion Date
November 30, 2021 (Actual)
Study Completion Date
May 30, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Oslo
Collaborators
Oslo Metropolitan University, University Hospital, Akershus, Helse Fonna, Diakonhjemmet Hospital, Vestre Viken Hospital Trust, Oslo University Hospital, Sykehuset i Vestfold HF, Sykehuset Telemark, The Research Council of Norway, Helse Sor-Ost

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study will develop and evaluate a complex intervention to implement guidelines on family involvement for patients with psychotic disorders (F20-29 in International Classification of Diseases ICD-10) in community mental health centres, by using a cluster randomised design. Fifteen Norwegian outpatient units participate in the study, and each of them constitutes a single cluster, except for two collaborating clinics who are considered one cluster. Of the fourteen clusters, half will receive implementation support and training immediately, whereas the other half will receive it one and a half year later. The study will assess both service level outcomes, by measuring fidelity scores, and selected outcomes for patients and relatives, by collecting questionnaires and data from central health registers and patient records. In addition, qualitative interviews will be performed with patients, relatives and health care personnel. The study will also include a cost-effectiveness analysis and a political economy analysis.
Detailed Description
Background: Family involvement during severe mental illness, such as psychotic disorders, is both important and challenging. Evidence suggest that family interventions for persons with psychotic disorders are associated with positive outcomes for both relatives and patients, and economic analyses of such interventions consistently report net saving. There are also important moral imperatives to involve those providing unpaid and informal care. Yet research has shown that relatives of patients with severe mental illness experience little involvement, and that the implementation of family interventions is patchy. The Norwegian national guidelines on family involvement in the public health- and care services and the national guidelines on psychotic disorders, both give recommendations on family involvement. However, there is little knowledge about how to achieve their implementation, and whether a high degree of implementation will be associated with improvements in selected outcomes for patients and relatives. Setting: Fifteen outpatient units from community mental health centres in the South-Eastern Norway Regional Health Authority. Research questions: What is the current level of implementation of the selected recommendations in the national guidelines on family involvement for persons with psychotic disorders in participating clinical units? What are important barriers to and facilitators for implementing the national guidelines among the stakeholders at the clinical, organisational, and policy level? What are important moral dilemmas and conflicting interests related to family involvement, and how can these be resolved? Is implementation of the selected recommendations increased by a comprehensive implementation support program, compared with no such support? Is a higher level of implementation of the selected recommendations associated with improvements in selected outcomes for patients and relatives? Is implementation of family involvement during primary psychotic disorders a cost-effective intervention? Hypotheses: The current implementation of the selected recommendations in the national guidelines on family involvement for persons with psychotic disorders is low. There are important barriers to and facilitators for implementing the national guidelines among the stakeholders, at the clinical, organisational and policy level. There are important moral dilemmas and conflicting interests, and these can be dealt with through systematic triadic approaches and ethics reflection. A comprehensive implementation program for the selected recommendations is associated with a significantly higher implementation of family involvement for persons with psychotic disorders, compared to no such specific program. Higher implementation of the selected recommendations is associated with improved outcomes for patients and relatives. Outcomes for relatives, patients and the public health- and welfare services justify the costs of implementing family involvement for persons with psychotic disorders.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychotic Disorders
Keywords
Family psychoeducation, Schizophrenia, Implementation science, Mental health care services, Clinical ethics, Family involvement, Family intervention

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study is a cluster randomised controlled trial. Fourteen clusters will be stratified into three strata according to their estimated number of patients with psychotic disorders currently in treatment. The clusters within each stratum will then be randomised to either intervention or control arms with an allocation ratio of 1:1.The seven outpatient units in the intervention arm receives a comprehensive implementation support program, whereas the outpatient clinics in the control arm receives no implementation support. A similar number of patients and relatives will be recruited from both arms, preferably in dyadic pairs, for the quantitative patient- and relative sub study. Employees from the clusters in the intervention arm will be recruited to answer a questionnaire, as part of the implementation study. Patients, relatives and employees will be recruited from the clusters in the intervention arm to take part in qualitative interviews.
Masking
None (Open Label)
Masking Description
Patients and relatives will not be informed about their outpatient clinic's allocation status. However, they may deduce this from the kind of treatment they receive. It's impossible to blind the care providers and for practical reasons we won't be able to blind the investigators or the outcomes assessors.
Allocation
Randomized
Enrollment
460 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention arm
Arm Type
Other
Arm Description
Clusters (psychiatric outpatient clinics) in the intervention arm receives a comprehensive implementation support program during the trial period.
Arm Title
Control arm
Arm Type
No Intervention
Arm Description
Clusters (psychiatric outpatient clinics) in the control arm receives no implementation support during the trial period.
Intervention Type
Other
Intervention Name(s)
Implementation support program
Intervention Description
The IFIP intervention consists of the following elements: I. Clinical interventions 1.1 A basic level of family involvement and support 1.2 Family psychoeducation in single-family groups II. Implementation interventions 2.1 Training and guidance of health care personnel 2.2 A family coordinator 2.3 Other implementation measures
Primary Outcome Measure Information:
Title
Implementation study: Fidelity to the intervention model - Family psychoeducation 1
Description
Change in score on fidelity scale for performance and content of family psychoeducation. Rated from 1 (low) to 5 (high).
Time Frame
Baseline, 6, 12 and 18 months in the intervention arm. Baseline and 18 months in the control arm.
Title
Implementation study: Fidelity to the intervention model - Family psychoeducation 2
Description
Change in score on fidelity scale for penetration rate and general organisation of family psychoeducation. Rated from 1 (low) to 5 (high).
Time Frame
Baseline, 6, 12 and 18 months in the intervention arm. Baseline and 18 months in the control arm.
Title
Implementation study: Fidelity to the intervention model - Family involvement and support 1
Description
Change in total fidelity measured by the fidelity scale for family involvement and support. Rated from 1 (low) to 5 (high).
Time Frame
Baseline, 6, 12 and 18 months in the intervention arm. Baseline and 18 months in the control arm.
Title
Implementation study: Fidelity to the intervention model - Family involvement and support 2
Description
Change in penetration rate, measured by the fidelity scale for family involvement and support. Rated from 1 (low) to 5 (high).
Time Frame
Baseline, 6, 12 and 18 months in the intervention arm. Baseline and 18 months in the control arm.
Title
Implementation study: Fidelity to the intervention model - Family involvement and support 3
Description
Change in content, structure and implementation, measured by the scale for family involvement and support. Rated from 1 (low) to 5 (high).
Time Frame
Baseline, 6, 12 and 18 months in the intervention arm. Baseline and 18 months in the control arm.
Secondary Outcome Measure Information:
Title
Patient quantitative sub-study: Patient experiences of their own mental health and functioning.
Description
The Behavior and Symptom Identification scale - (BASIS-24) with 24 questions on mental health, functioning and substance use, on a scale 1-5. Completed by patients.
Time Frame
0, 6 and 12 months.
Title
Patient quantitative sub-study and economic sub-study: Quality of life
Description
The Recovering Quality of Life - (ReQoL-10) questionnaire with 10 mental health items, and one physical health item on a scale 1-5. Completed by patients.
Time Frame
0, 6 and 12 months.
Title
Patient quantitative sub-study: General satisfaction.
Description
The Manchester Short Assesment of Quality of Life - (MANSA) questionnaire - first question only, on a scale 1-7. Completed by patients.
Time Frame
0, 6 and 12 months.
Title
Patient quantitative sub-study: Experienced burden of mental health problems.
Description
A single question - Produced for this study on a scale 1-7. Completed by patients.
Time Frame
0, 6 and 12 months.
Title
Patient quantitative sub-study: Perceived warmth and criticism from relative.
Description
Hooley 1989 - 5 items rated 1-10. Completed by patients.
Time Frame
0, 6 and 12 months.
Title
Patient quantitative sub-study: Experienced shared decision making.
Description
The CollaboRATE questionnaire (3 items rated 0-9), plus two additional items. Completed by patients.
Time Frame
0, 6 and 12 months.
Title
Patient quantitative sub-study: Adherence with medication
Description
A single question answered by patient, relative and clinician.
Time Frame
0, 6 and 12 months for patients and relatives. 0 and 12 months for clinicians.
Title
Patient quantitative sub-Study: Clinician assessment of patient mental health and functioning
Description
Health of the Nation Outcome Scale - (HoNOS) scale rated by clinicians on 12 items rated 0-4 (no problem - very serious problem).
Time Frame
0 and 12 months.
Title
Patient quantitative sub-study: Clinician assessment of patient global functioning
Description
Global Assessment of Functioning Scale - (GAF), split version for symptoms and functioning
Time Frame
0 and 12 months.
Title
Patient quantitative sub-study and economic sub-study: Change in number of hospital admissions.
Description
Retrieved from the Norwegian patient registry.
Time Frame
Measured from 18 months before inclusion to 18 months after inclusion.
Title
Patient quantitative sub-study and economic sub-study: Change in number of days spent admitted to hospital.
Description
Retrieved from the Norwegian patient registry.
Time Frame
Measured from 18 months before inclusion to 18 months after inclusion.
Title
Relative quantitative sub-study and economic sub-study: Caregiver quality of life 1
Description
The Care Related Quality of Life - (CarerQoL) questionnaire - Seven questions on a three-point scale. Completed by relatives.
Time Frame
0, 6 and 12 months.
Title
Relative quantitative sub-study and economic sub-study: Caregiver quality of life 2
Description
The Care Related Quality of Life - (CarerQoL) questionnaire - One visual analogue scale (VAS)-question on an 11-point scale, which is also part of the same measure. Completed by relatives.
Time Frame
0, 6 and 12 months.
Title
Relative quantitative sub-study: Experience of caregiving
Description
The Experience of Caregiving inventory - (ECI) questionnaire - 66 items on a five-point scale covering various aspects of being a caregiver. Completed by relatives.
Time Frame
0, 6 and 12 months.
Title
Relative quantitative sub-study: Expressed emotion
Description
The Family questionnaire - (FQ) - 20 items on a four-point scale, measuring criticism and emotional over-involvement. Completed by relatives.
Time Frame
0, 6 and 12 months.
Title
Relative quantitative sub-study: Experienced involvement and shared decision making
Description
An adapted version of the CollaboRATE questionnaire (3 items rated 0-9), plus two additional items completed by relatives.
Time Frame
0, 6 and 12 months.
Title
Relative quantitative sub-study: Experienced support
Description
Carer Well-being and Support questionnaire (CWS) v2 short part B - 18 items rated on a four-point scale. Completed by relatives.
Time Frame
0, 6 and 12 months.
Title
Patients' and relatives' quantitative sub-studies and economic sub-study: Use of public health services and resources.
Description
Patients' and relatives' use of public health services and resources: Number of appointments with health services, investigations, treatments and medical prescriptions, translated into costs. Retrieved from national registries.
Time Frame
Measured from 18 months before inclusion to 18 months after inclusion.
Title
Patients' and relatives' quantitative sub-studies and economic sub-study: Work participation
Description
Patients' and relatives' work participation measured in percentage of a regular full time position. Retrieved from national registries.
Time Frame
Measured from 18 months before inclusion to 18 months after inclusion.
Title
Economic sub-study: Increased costs related to implementing and practicing family involvement
Description
Increased costs related to implementing and practicing family involvement in the clinical units in the intervention arm. Compared to normal costs before baseline.
Time Frame
Measured before baseline and then throughout the implementation period (0-18 months).
Other Pre-specified Outcome Measures:
Title
Patient quantitative sub-study: Alcohol abuse
Description
The Alcohol Use Disorders Identification Test - (AUDIT) - 10 items on a five-point scale. Completed by patients.
Time Frame
0 months - baseline screening only
Title
Patient quantitative sub-study: Drug abuse
Description
The Drug Use Disorders Identification Test - (DUDIT) - 11 items on a three to five-point scale. Completed by patients.
Time Frame
0 months - baseline screening only
Title
Patient quantitative sub-study and implementation study: Exposure to family psychoeducation.
Description
Participation in family psychoeducation measured in number and type of sessions. Reported by both patient and clinician.
Time Frame
Baseline screening, then 6 and 12 months
Title
Relative quantitative sub-study and implementation study: Exposure to psychoeducation.
Description
Participation in family psychoeducation measured in number and type of sessions. Reported by relative.
Time Frame
Baseline screening, then 6 and 12 months
Title
Relative quantitative sub-study and implementation study: Exposure to family involvement.
Description
Use of different services to involve and support relatives: Family therapy, group support meetings, meetings with the patients' health care personnel, therapy, education on mental health and illness.
Time Frame
Baseline screening, then 6 and 12 months
Title
Implementation study: Clinician readiness for change
Description
Implementation Process Assessment Tool - (IPAT) a questionnaire (27 items rated 1-6) regarding experience of implementation of a specified practice. Completed by clinicians
Time Frame
0, 6 and 12 months, approximately.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Eligibility criteria apply to participants in both quantitative and qualitative sub-studies, except that participation in family psychoeducation as described below is NOT an exclusion criterion in the qualitative sub-study. Inclusion criteria for patients: To have an established psychotic disorder (F20-29 in ICD-10) or a tentative diagnosis of psychotic disorder, certain enough to begin treatment. This need not be the patient's primary diagnosis. To be 18 years or older at the time of inclusion. Exclusion criteria for patients: To be sentenced to psychiatric treatment. Not being competent to consent to participation in research. Having completed more than five joint sessions of family psychoeducation in single-family groups (patient and relative together) or more than ten joint sessions (multiple families together) in multiple-family groups, or a similarly structured family intervention. Not having any relatives or next of kin. Inclusion criteria for relatives: Being a relative of a patient with a diagnosis as described above. To be 18 years or older at the time of inclusion. Exclusion criteria for relatives: • Having completed more than five joint sessions (patient and relative together) of family psychoeducation in single-family groups or more than ten joint sessions (multiple families together) in multiple-family groups, or a similarly structured family intervention.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Reidar Pedersen, PhD
Organizational Affiliation
Professor and head of department, Centre for medical ethics,University of Oslo
Official's Role
Principal Investigator
Facility Information:
Facility Name
Asker DPS - Vestre Viken HF
City
Asker
Country
Norway
Facility Name
Drammen DPS - Vestre Viken HF
City
Drammen
Country
Norway
Facility Name
Ringerike DPS - Vestre Viken HF
City
Hønefoss
Country
Norway
Facility Name
Kongsberg DPS - Vestre Viken HF
City
Kongsberg
Country
Norway
Facility Name
DPS poliklinikk Vestmar/stathelle - Sykehuset Telemark
City
Kragerø
Country
Norway
Facility Name
Vestfold DPS - Sykehuset i Vestfold HF
City
Larvik
Country
Norway
Facility Name
Nedre Romerike DPS - Akershus Universitetssykehus HF
City
Lillestrøm
Country
Norway
Facility Name
Groruddalen DPS - Akershus Universitetssykehus HF
City
Oslo
Country
Norway
Facility Name
Søndre Oslo DPS - Oslo Universitetssykehus HF
City
Oslo
Country
Norway
Facility Name
Voksenpsykiatrisk avdeling Vinderen - Diakonhjemmet Sykehus
City
Oslo
Country
Norway
Facility Name
DPS poliklinikk Porsgrunn - Sykehuset Telemark
City
Porsgrunn
Country
Norway
Facility Name
Bærum DPS -Vestre Viken HF
City
Sandvika
Country
Norway
Facility Name
DPS poliklinikk Seljord - Sykehuset Telemark
City
Seljord
Country
Norway
Facility Name
DPS poliklinikk Skien - Sykehuset Telemark
City
Skien
Country
Norway
Facility Name
Vestfold DPS - Sykehuset i Vestfold HF
City
Tønsberg
Country
Norway

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
15550803
Citation
Eisen SV, Normand SL, Belanger AJ, Spiro A 3rd, Esch D. The Revised Behavior and Symptom Identification Scale (BASIS-R): reliability and validity. Med Care. 2004 Dec;42(12):1230-41. doi: 10.1097/00005650-200412000-00010.
Results Reference
background
PubMed Identifier
29433611
Citation
Keetharuth AD, Brazier J, Connell J, Bjorner JB, Carlton J, Taylor Buck E, Ricketts T, McKendrick K, Browne J, Croudace T, Barkham M. Recovering Quality of Life (ReQoL): a new generic self-reported outcome measure for use with people experiencing mental health difficulties. Br J Psychiatry. 2018 Jan;212(1):42-49. doi: 10.1192/bjp.2017.10.
Results Reference
background
PubMed Identifier
23768763
Citation
Elwyn G, Barr PJ, Grande SW, Thompson R, Walsh T, Ozanne EM. Developing CollaboRATE: a fast and frugal patient-reported measure of shared decision making in clinical encounters. Patient Educ Couns. 2013 Oct;93(1):102-7. doi: 10.1016/j.pec.2013.05.009. Epub 2013 Jun 12.
Results Reference
background
PubMed Identifier
10443245
Citation
Priebe S, Huxley P, Knight S, Evans S. Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry. 1999 Spring;45(1):7-12. doi: 10.1177/002076409904500102.
Results Reference
background
PubMed Identifier
8766459
Citation
Szmukler GI, Burgess P, Herrman H, Benson A, Colusa S, Bloch S. Caring for relatives with serious mental illness: the development of the Experience of Caregiving Inventory. Soc Psychiatry Psychiatr Epidemiol. 1996 Jun;31(3-4):137-48. doi: 10.1007/BF00785760.
Results Reference
background
PubMed Identifier
16900281
Citation
Brouwer WB, van Exel NJ, van Gorp B, Redekop WK. The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res. 2006 Aug;15(6):1005-21. doi: 10.1007/s11136-005-5994-6.
Results Reference
background
PubMed Identifier
11959363
Citation
Wiedemann G, Rayki O, Feinstein E, Hahlweg K. The Family Questionnaire: development and validation of a new self-report scale for assessing expressed emotion. Psychiatry Res. 2002 Apr 15;109(3):265-79. doi: 10.1016/s0165-1781(02)00023-9.
Results Reference
background
Citation
Quirk, A., Smith, S., Hamilton, S., Lamping, D., Lelliot, P., Stahl, D., Pinfold, V & Andiappan, M. (2012). Development of the carer well-being and support (CWS) questionnaire. Mental Health Review Journal 17:128-38.doi:10.1108/13619321211287184
Results Reference
background
PubMed Identifier
9534825
Citation
Wing JK, Beevor AS, Curtis RH, Park SB, Hadden S, Burns A. Health of the Nation Outcome Scales (HoNOS). Research and development. Br J Psychiatry. 1998 Jan;172:11-8. doi: 10.1192/bjp.172.1.11.
Results Reference
background
PubMed Identifier
15608468
Citation
Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11(1):22-31. doi: 10.1159/000081413.
Results Reference
background
PubMed Identifier
8329970
Citation
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993 Jun;88(6):791-804. doi: 10.1111/j.1360-0443.1993.tb02093.x.
Results Reference
background
Citation
Karterud S, Pedersen G, Løvdal H, Friis S. S-GAF: Global Funsjonsskåring - Splittet Versjon [Global Assessment of Functioning - Split version]. Bakgrunn og skåringsveiledning. Klinikk for psykiatri, Ullevål sykehus, Oslo, 1998.
Results Reference
background
PubMed Identifier
2768657
Citation
Hooley JM, Teasdale JD. Predictors of relapse in unipolar depressives: expressed emotion, marital distress, and perceived criticism. J Abnorm Psychol. 1989 Aug;98(3):229-35. doi: 10.1037//0021-843x.98.3.229.
Results Reference
background
PubMed Identifier
21154340
Citation
Pharoah F, Mari J, Rathbone J, Wong W. Family intervention for schizophrenia. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD000088. doi: 10.1002/14651858.CD000088.pub2.
Results Reference
background
PubMed Identifier
25833867
Citation
Yesufu-Udechuku A, Harrison B, Mayo-Wilson E, Young N, Woodhams P, Shiers D, Kuipers E, Kendall T. Interventions to improve the experience of caring for people with severe mental illness: systematic review and meta-analysis. Br J Psychiatry. 2015 Apr;206(4):268-74. doi: 10.1192/bjp.bp.114.147561.
Results Reference
background
Citation
Helsedirektoratet. (2013). Utredning, behandling og oppfølging av personer med psykoselidelser. Retrieved March 22, 2018, from https://helsedirektoratet.no/Lists/Publikasjoner/Attachments/326/Nasjonal-faglig-retningslinje-for-utredning-behandling-og-oppfolging-av-personer-med-psykoselidelser-IS-1957.pdf.
Results Reference
background
Citation
Helsedirektoratet. (2017). Veileder om pårørende i helse- og omsorgstjenesten. Retrieved March 22, 2018, from https://helsedirektoratet.no/Retningslinjer/Pårørendeveileder.pdf
Results Reference
background
PubMed Identifier
17914003
Citation
McHugo GJ, Drake RE, Whitley R, Bond GR, Campbell K, Rapp CA, Goldman HH, Lutz WJ, Finnerty MT. Fidelity outcomes in the National Implementing Evidence-Based Practices Project. Psychiatr Serv. 2007 Oct;58(10):1279-84. doi: 10.1176/ps.2007.58.10.1279.
Results Reference
background
Citation
Vermeulen, B., Lauwers, H., Spruytte, N., Van Audenhove, C., Magro, C., Saunders, J. & Jones, K. (2015). Experiences of family caregivers for persons with severe mental illness: an international exploration. Leuven: LUCAS KU Leuven/EUFAMI.
Results Reference
background
PubMed Identifier
11141527
Citation
Torrey WC, Drake RE, Dixon L, Burns BJ, Flynn L, Rush AJ, Clark RE, Klatzker D. Implementing evidence-based practices for persons with severe mental illnesses. Psychiatr Serv. 2001 Jan;52(1):45-50. doi: 10.1176/appi.ps.52.1.45.
Results Reference
background
PubMed Identifier
22951546
Citation
Campbell MK, Piaggio G, Elbourne DR, Altman DG; CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012 Sep 4;345:e5661. doi: 10.1136/bmj.e5661. No abstract available.
Results Reference
background
PubMed Identifier
36096844
Citation
Hansson KM, Romoren M, Pedersen R, Weimand B, Hestmark L, Norheim I, Ruud T, Hymer IS, Heiervang KS. Barriers and facilitators when implementing family involvement for persons with psychotic disorders in community mental health centres - a nested qualitative study. BMC Health Serv Res. 2022 Sep 12;22(1):1153. doi: 10.1186/s12913-022-08489-y.
Results Reference
derived
PubMed Identifier
34078306
Citation
Hestmark L, Heiervang KS, Pedersen R, Hansson KM, Ruud T, Romoren M. Family involvement practices for persons with psychotic disorders in community mental health centres - a cross-sectional fidelity-based study. BMC Psychiatry. 2021 Jun 2;21(1):285. doi: 10.1186/s12888-021-03300-4.
Results Reference
derived
PubMed Identifier
33036605
Citation
Hestmark L, Romoren M, Heiervang KS, Weimand B, Ruud T, Norvoll R, Hansson KM, Norheim I, Aas E, Landeweer EGM, Pedersen R. Implementation of guidelines on family involvement for persons with psychotic disorders in community mental health centres (IFIP): protocol for a cluster randomised controlled trial. BMC Health Serv Res. 2020 Oct 9;20(1):934. doi: 10.1186/s12913-020-05792-4.
Results Reference
derived

Learn more about this trial

Implementation of Family Involvement for Persons With Psychotic Disorders.

We'll reach out to this number within 24 hrs